India, July 25 -- The shares of this small cap company majorly engaged in manufacturing of chemicals providing essential derivatives and specialty chemicals with commitment to sustainability, advanced manufacturing capabilities and many more were in focus after the brokerage sees x percent upside potential.

With the market capitalization of Rs. 5016 Crores, the shares of Epigral Ltd were trading at around Rs. 1163 per share which is 45 percent discount from its 52 week high of Rs. 2114 per share and is trading at a P/E of 15.2 whereas industry P/E stands at 30.7

Brokerage view Systematix has initiated coverage on Epigral with a 'Buy' rating and a target price of 1380 implying an upside potential of around x%. The brokerage believes th...